Colitis-associated colorectal cancer(CAC),a serious complication of ulcerative colitis(UC),is associated with a poor prognosis.The vitamin D receptor(VDR)is recognized for its protective role in UC and CAC through the...Colitis-associated colorectal cancer(CAC),a serious complication of ulcerative colitis(UC),is associated with a poor prognosis.The vitamin D receptor(VDR)is recognized for its protective role in UC and CAC through the maintenance of intestinal barrier integrity and the regulation of inflammation.This study demonstrates a significant reduction in m^(6)A-related genes,particularly methyltransferase like 14(METTL14),in UC and CAC patients and identifies an association between METTL14 and VDR.In the azoxymethane(AOM)/dextran sodium sulfate(DSS)-induced mousemodel,vitamin D treatment increases METTL14 expression and reduces tumorburden,while Vdr-knockout mice exhibit lower METTL14 levels and increased tumorigenesis.In vitro,the VDR agonist calcipotriol upregulates METTL14 in NCM460 cells,with this effect attenuated by VDR knockdown.VDRknockdown inDLD-1colon cancer cellsdecreases METTL14 expressionand promotes proliferation,which is reversed by METTL14 overexpression.Mechanistic studies reveal that VDR regulates METTL14 expression via promoter binding,modulating key target genes such as SOX4,DROSH,and PHLPP2.This study highlights the role of the VDR-METTL14 axis as a protective mechanism in CAC and suggests its potential as a therapeutic target for preventing and treating CAC.展开更多
基金funded by National High-Level Hospital Clinical Research Funding (2022-PUMCH-A-203)CAMS Innovation Fund for Medical Sciences (2021-I2M-1-001)+4 种基金Health Research & Special Projects Grant of China (201002020 and 201502005)The Integrated Entrusted Project of Research Funding at Peking Union Medical College Hospital (ZC201903347)the National Natural Science Foundation of China (81970495)Capital Health Development Scientific Research Fund (2022-2-4014)Peking Union Medical College Hospital Research Funding for Postdoc (kyfyjj202315)
文摘Colitis-associated colorectal cancer(CAC),a serious complication of ulcerative colitis(UC),is associated with a poor prognosis.The vitamin D receptor(VDR)is recognized for its protective role in UC and CAC through the maintenance of intestinal barrier integrity and the regulation of inflammation.This study demonstrates a significant reduction in m^(6)A-related genes,particularly methyltransferase like 14(METTL14),in UC and CAC patients and identifies an association between METTL14 and VDR.In the azoxymethane(AOM)/dextran sodium sulfate(DSS)-induced mousemodel,vitamin D treatment increases METTL14 expression and reduces tumorburden,while Vdr-knockout mice exhibit lower METTL14 levels and increased tumorigenesis.In vitro,the VDR agonist calcipotriol upregulates METTL14 in NCM460 cells,with this effect attenuated by VDR knockdown.VDRknockdown inDLD-1colon cancer cellsdecreases METTL14 expressionand promotes proliferation,which is reversed by METTL14 overexpression.Mechanistic studies reveal that VDR regulates METTL14 expression via promoter binding,modulating key target genes such as SOX4,DROSH,and PHLPP2.This study highlights the role of the VDR-METTL14 axis as a protective mechanism in CAC and suggests its potential as a therapeutic target for preventing and treating CAC.
